| Dr Matthew Patrick Sullivan, MD | |
|
6620 Fly Rd, Ste 200, East Syracuse, NY 13057-9791 | |
| (315) 464-4472 | |
| Not Available |
| Full Name | Dr Matthew Patrick Sullivan |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 14 Years |
| Location | 6620 Fly Rd, East Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750609004 | NPI | - | NPPES |
| 04488400 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | MD60545599 (Washington) | Primary |
| 207X00000X | Orthopaedic Surgery | MD60545599 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital S U N Y Health Science Center | Syracuse, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upstate Orthopedics, Llp | 1456344514 | 32 |
News Archive
University of Adelaide researchers have invented a world-first tiny fiber-optic probe that can simultaneously measure temperature and see deep inside the body.
The study by a team at Shaare Zedek Medical Centre in Jerusalem, is the first to examine what couples actually did when they learned their unborn child had a condition called Gaucher disease, an inherited condition which can be effectively treated.
A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)s not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.
The current pandemic of COVID-19 is caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), a betacoronavirus similar to that which caused the SARS-CoV and MERS-CoV earlier. Scientists are pursuing therapeutic drugs and vaccines to counter the relentless spread of the virus, but so far, none has been established to be effective. However, several are in clinical trials in various parts of the world.
A novel, lower-dose formulation of indomethacin, a widely used pain reliever, is absorbed faster by the body than a standard formulation and maintains comparable maximum concentrations in the blood despite being administered at a lower dose, according to a study to be reported here tomorrow at the annual meeting of the American Headache Society.
› Verified 5 days ago
| Entity Name | Upstate Orthopedics, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740228311 PECOS PAC ID: 1456344514 Enrollment ID: O20040405001452 |
News Archive
University of Adelaide researchers have invented a world-first tiny fiber-optic probe that can simultaneously measure temperature and see deep inside the body.
The study by a team at Shaare Zedek Medical Centre in Jerusalem, is the first to examine what couples actually did when they learned their unborn child had a condition called Gaucher disease, an inherited condition which can be effectively treated.
A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)s not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.
The current pandemic of COVID-19 is caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), a betacoronavirus similar to that which caused the SARS-CoV and MERS-CoV earlier. Scientists are pursuing therapeutic drugs and vaccines to counter the relentless spread of the virus, but so far, none has been established to be effective. However, several are in clinical trials in various parts of the world.
A novel, lower-dose formulation of indomethacin, a widely used pain reliever, is absorbed faster by the body than a standard formulation and maintains comparable maximum concentrations in the blood despite being administered at a lower dose, according to a study to be reported here tomorrow at the annual meeting of the American Headache Society.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Patrick Sullivan, MD 6620 Fly Rd, Ste 200, East Syracuse, NY 13057-9791 Ph: (315) 464-4472 | Dr Matthew Patrick Sullivan, MD 6620 Fly Rd, Ste 200, East Syracuse, NY 13057-9791 Ph: (315) 464-4472 |
News Archive
University of Adelaide researchers have invented a world-first tiny fiber-optic probe that can simultaneously measure temperature and see deep inside the body.
The study by a team at Shaare Zedek Medical Centre in Jerusalem, is the first to examine what couples actually did when they learned their unborn child had a condition called Gaucher disease, an inherited condition which can be effectively treated.
A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)s not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.
The current pandemic of COVID-19 is caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), a betacoronavirus similar to that which caused the SARS-CoV and MERS-CoV earlier. Scientists are pursuing therapeutic drugs and vaccines to counter the relentless spread of the virus, but so far, none has been established to be effective. However, several are in clinical trials in various parts of the world.
A novel, lower-dose formulation of indomethacin, a widely used pain reliever, is absorbed faster by the body than a standard formulation and maintains comparable maximum concentrations in the blood despite being administered at a lower dose, according to a study to be reported here tomorrow at the annual meeting of the American Headache Society.
› Verified 5 days ago
Dr. Maria Iannolo, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Rd, East Syracuse, NY 13057 Phone: 315-464-4472 Fax: 315-464-5222 | |
Scott M Vanvalkenburg, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Rd, Ste 200, East Syracuse, NY 13057 Phone: 315-464-4472 Fax: 315-464-5229 | |
Dr. William F Lavelle, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Road, Suite 200, East Syracuse, NY 13057 Phone: 315-464-4472 Fax: 315-464-5222 | |
Dr. Brian J Harley, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Road, Ste 200, East Syracuse, NY 13027 Phone: 315-464-4472 Fax: 315-464-5222 | |
David Cinats, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Rd Ste 100, East Syracuse, NY 13057 Phone: 315-464-4472 | |
Dr. Kathryn E Palomino, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Road, Ste 200, East Syracuse, NY 13057 Phone: 315-464-4472 | |
Robert A Sherman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Rd, Upstate Orthopedics, East Syracuse, NY 13057 Phone: 315-464-4472 Fax: 315-464-5221 |